Cargando…

Cost of clinical events in health economic evaluations in Germany: a systematic review

Guidance from the Institute for Quality and Efficiency in Health Care (IQWiG) on cost estimation in cost–benefit assessments in Germany acknowledges the need for standardization of costing methodology. The objective of this review was to assess current methods for deriving clinical event costs in Ge...

Descripción completa

Detalles Bibliográficos
Autores principales:	Scheuringer, Monika, Sahakyan, Narine, Krobot, Karl J, Ulrich, Volker
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3495193/ https://www.ncbi.nlm.nih.gov/pubmed/22651885 http://dx.doi.org/10.1186/1478-7547-10-7

Ejemplares similares

Cost-effectiveness of extended-release niacin/laropiprant added to a stable simvastatin dose in secondary prevention patients not at cholesterol goal in Germany
por: Michailov, Galin V., et al.
Publicado: (2011)

Costs and where to find them: identifying unit costs for health economic evaluations of diabetes in France, Germany and Italy
por: Pöhlmann, J., et al.
Publicado: (2020)

Health economic evaluations based on routine data in Germany: a systematic review
por: Gansen, Fabia Mareike
Publicado: (2018)

Costs of treating cardiovascular events in Germany: a systematic literature review
por: Schmid, Tamara
Publicado: (2015)

Longitudinal evaluation of intensive care unit-related fluconazole use in Spain and Germany
por: Wissing, H, et al.
Publicado: (2007)

Erratum to: ‘Costs of treating cardiovascular events in Germany: a systematic literature review’
por: Schmid, Tamara, et al.
Publicado: (2016)

Caspofungin for treatment of invasive aspergillosis in Germany: results of a pre-planned subanalysis of an international registry
por: Egerer, Gerlinde, et al.
Publicado: (2012)

Modelling of life cycle cost of conventional and alternative vehicles
por: Furch, Jan, et al.
Publicado: (2022)

Programme costs in the economic evaluation of health interventions
por: Johns, Benjamin, et al.
Publicado: (2003)

An Evaluation of Clinical Economics and Cases of Cost-effectiveness
por: Takura, Tomoyuki
Publicado: (2017)

Evaluating the cost effectiveness of donepezil in the treatment of Alzheimer's disease in Germany using discrete event simulation
por: Hartz, Susanne, et al.
Publicado: (2012)

Central COVID-19 Coordination Centers in Germany: Description, Economic Evaluation, and Systematic Review
por: Schopow, Nikolas, et al.
Publicado: (2021)

Costs and its drivers for diabetes mellitus type 2 patients in France and Germany: a systematic review of economic studies
por: Stegbauer, Constance, et al.
Publicado: (2020)

Health economic evaluation of vaccination strategies for the prevention of herpes zoster and postherpetic neuralgia in Germany
por: Ultsch, Bernhard, et al.
Publicado: (2013)

Comparable worth of life for all? Conducting and disseminating health economic evaluations for refugees in Germany
por: Biddle, Louise, et al.
Publicado: (2022)

Intensive care unit-related fluconazole use in Spain and Germany: patient characteristics and outcomes of a prospective multicenter longitudinal observational study
por: Wissing, Heimo, et al.
Publicado: (2013)

How an aging society affects the economic costs of inactivity in Germany: empirical evidence and projections
por: Dallmeyer, Sören, et al.
Publicado: (2017)

Willingness to bear economic costs of measures against SARS-CoV-2 in Germany
por: König, Hans-Helmut, et al.
Publicado: (2021)

Assessing the Economic Burden and Benefit-cost of Treating Attention-deficit Hyperactivity Disorder in Germany
por: Kotsopoulos, Nikolaos, et al.
Publicado: (2013)

Multiple myeloma in Armenia during the period 2006–2018: facts and discussion
por: Ghazaryan, Narine, et al.
Publicado: (2021)

Clinical effectiveness and cost-effectiveness of pegvisomant for the treatment of acromegaly: a systematic review and economic evaluation
por: Moore, David J, et al.
Publicado: (2009)

Costs of patients with chronic kidney disease in Germany
por: Gandjour, Afschin, et al.
Publicado: (2020)

Health Promotion for Outpatient Careworkers in Germany
por: Mojtahedzadeh, Natascha, et al.
Publicado: (2022)

Economic Evaluation of Telerehabilitation: Systematic Literature Review of Cost-Utility Studies
por: Baffert, Sandrine, et al.
Publicado: (2023)

Unit Costs in Health Economic Evaluations: Quo Vadis, Austria?
por: Mayer, Susanne, et al.
Publicado: (2022)

The Economic Costs of Progressive Supranuclear Palsy and Multiple System Atrophy in France, Germany and the United Kingdom
por: McCrone, Paul, et al.
Publicado: (2011)

A retrospective cost-analysis of additional homeopathic treatment in Germany: Long-term economic outcomes
por: Ostermann, Julia K., et al.
Publicado: (2017)

Macromastia: an economic burden? A disease cost analysis based on real-world data in Germany
por: Jud, Sebastian M., et al.
Publicado: (2020)

Cost-effectiveness evidence of mental health prevention and promotion interventions: A systematic review of economic evaluations
por: Le, Long Khanh-Dao, et al.
Publicado: (2021)

Index hospital cost of adverse events following thoracic surgery: a systematic review of economic literature
por: Jones, Daniel, et al.
Publicado: (2023)

Atosiban versus betamimetics in the treatment of preterm labour in Germany: an economic evaluation
por: Wex, Jaro, et al.
Publicado: (2009)

Economic Evaluation in Duchenne Muscular Dystrophy: Model Frameworks for Cost-Effectiveness Analysis
por: Landfeldt, Erik, et al.
Publicado: (2016)

Health care cost containment in the Federal Republic of Germany
por: Schneider, Markus
Publicado: (1991)

Costs and economic evaluations of Quality Improvement Collaboratives in healthcare: a systematic review
por: de la Perrelle, Lenore, et al.
Publicado: (2020)

Global systematic review of cost of illness and economic evaluation studies associated with snakebite
por: Patikorn, Chanthawat, et al.
Publicado: (2020)

Economic evaluations and cost analyses in posttraumatic stress disorder: a systematic review
por: von der Warth, Rieka, et al.
Publicado: (2020)

Health care use and costs of adverse drug events emerging from outpatient treatment in Germany: A modelling approach
por: Stark, Renee G, et al.
Publicado: (2011)

Fear of hypoglycaemia: defining a minimum clinically important difference in patients with type 2 diabetes
por: Stargardt, Tom, et al.
Publicado: (2009)

Heterogeneity of cost estimates in health economic evaluation research. A systematic review of stress urinary incontinence studies
por: Zwolsman, Sandra, et al.
Publicado: (2019)

Cost-effectiveness analysis of paediatric mental health interventions: a systematic review of model-based economic evaluations
por: Kularatna, Sanjeewa, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ddq9biq5c0q37h45b66hreliif